These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24354801)

  • 1. The effects of fasting in Muslim patients taking warfarin.
    Lai YF; Cheen MH; Lim SH; Yeo FH; Nah SC; Kong MC; Mya D; Lee LH; Ng HJ
    J Thromb Haemost; 2014; 12(3):349-54. PubMed ID: 24354801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does fasting during Ramadan influence the therapeutic effect of warfarin?
    Sridharan K; Al Banna R; Qader AM; Husain A
    J Clin Pharm Ther; 2021 Feb; 46(1):86-92. PubMed ID: 32926452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Ramadan fasting disrupt international normalised ratio control in warfarin-treated medically stable patients?
    Alwhaibi A; Alenazi M; Alwagh F; Al-Ghayhab A; Alghadeer S; Bablghaith S; Wajid S; Al-Arifi M
    Int J Clin Pract; 2021 Nov; 75(11):e14796. PubMed ID: 34482618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Ramadan fasting on patients with prosthetic heart valve taking warfarin for anticoagulation.
    Awiwi MO; Yagli ZA; Elbir F; Aglar AA; Guler E; Vural U
    J Saudi Heart Assoc; 2017 Jan; 29(1):1-6. PubMed ID: 28127212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? a systematic review and meta-analysis.
    Rabea EM; Abbas KS; Awad DM; Elgoweini NH; El-Sakka AA; Mahmoud NH; Abdelazeem B
    Eur J Clin Pharmacol; 2022 May; 78(5):755-763. PubMed ID: 35179616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulation therapy using acenocoumarol during the month of ramadan: a comparative study between fasting and non-fasting patients.
    Zghal Mghaieth F; Bonkano A; Boudiche S; Ayari J; Ben Mansour N; Rekik B; Ben Halima M; Ouali S; Mourali MS
    Tunis Med; 2019 Oct; 97(10):1177-1186. PubMed ID: 31691946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new regimen for starting warfarin therapy in out-patients.
    Oates A; Jackson PR; Austin CA; Channer KS
    Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
    Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ramadan fasting on acenocoumarol-induced antocoagulant effect.
    Mzoughi K; Zairi I; Fennira S; Kamoun S; Jnifene Z; Ben Moussa F; Kraiem S
    Ann Biol Clin (Paris); 2017 Oct; 75(5):513-518. PubMed ID: 28958959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range.
    Dinç Asarcıklı L; Kafes H; Şen T; Gucuk İpek E; Cebeci M; Gül M; Kanat S; Temizhan A
    Turk Kardiyol Dern Ars; 2021 Sep; 49(6):463-473. PubMed ID: 34523594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2).
    Barnes GD; Kaatz S; Golgotiu V; Gu X; Leidal A; Kobeissy A; Haymart B; Kline-Rogers E; Kozlowski J; Almany S; Leyden T; Froehlich JB
    J Thromb Thrombolysis; 2013 Jan; 35(1):10-4. PubMed ID: 22797905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.